Navigation Links
EntreMed in Medical Technology

Entremed Presents Results of ENMD-2076 Phase 1 Study in Advanced Cancer Patients

... antitumor activity in preclinical models. entremed Vice President and Chief Medical Officer, Carolyn ...e pathology of hematological cancers. About entremed EntreMed, Inc. is a clinical-stage pharmaceutic...heumatoid arthritis. Additional information about entremed is available on the Company's web site at www.en...

EntreMed Presents Initial Clinical Results for ENMD-2076

...based chemotherapy in breast cancer. In addition, entremed has received an Orphan Drug Designation from the F...g candidate, a No Objection Letter was received by entremed from Health Canada permitting ENMD-2076 to be used...ther expand the clinical development of ENMD-2076, entremed has received a No Objection Letter (NOL) from the ...

EntreMed Receives New Patent for 2-Methoxyestradiol Analogs

...s of 2- methoxyestradiol (2ME2). The patent grants entremed composition-of-matter and method of use intellectu...MDLOGO ) Analogs of 2ME2 have been developed by entremed to improve metabolic stability and retain or enhan...s owned exclusively by EntreMed. James S. Burns, entremed President & Chief Executive Officer, commented, "T...

EntreMed Presents MKC-1 Phase 2 Data at American Society of Clinical Oncology Annual Meeting

...taxel-resistant models. To date, MKC-1 has been evaluated in over 400 patients in multiple Phase 1 and 2 clinical trials. Carolyn F. Sidor, MD, MBA, entremed Vice President and Chief Medical Officer commented on the results, "Although we did not meet our overall goal for this study, we are encouraged by the...

EntreMed to Highlight ENMD-2076 Kinase Inhibitor at 2008 AACR Annual Meeting

...n/prnh/20010620/ENMDLOGO ) Mark R. Bray, Ph.D., entremed Vice President, Research, will give an oral presen...the special session, "New Drugs on the Horizon 2." entremed will share the podium with representatives from le...ies without cardiovascular effects. In addition, entremed scientists are scheduled for the following poster ...

EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program

...ogical cancers later this year." James S. Burns, entremed President & Chief Executive Officer commented, "EN... Phase 1 study will trigger a milestone payment by entremed pursuant to EntreMed's acquisition of Miikana Ther... Miikana stockholders, either in cash or shares of entremed common stock. About EntreMed EntreMed, Inc. is...

EntreMed Commences Continuous Dosing Clinical Trial For MKC-1

...effect with novel molecular imaging techniques," commented Dr. Glenn Liu. entremed Vice President and Chief Medical Officer, Carolyn F. Sidor, M.D., M.B.A., c... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed to Present at The New York Society of Security Analysts Industry Conference

...egulation and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission. CONTACT: ...

EntreMed Commences Phase 2 Study with MKC-1 in Pancreatic Cancer

... of the cell cycle, and induce apoptosis. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commented on the study, "Pancreat... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://www.entremed.com and in ...

EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model

...survival in cancer patients. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ot a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Reports Phase 1 PK and Preclinical Efficacy Results for ENMD-1198

...s overall antitumor effects. Mark R. Bray, Ph.D., entremed Vice President, Research, commented on the results...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Raises $20 Million to Support Clinical Development Program

...less fees, was funded at closing. James S. Burns, entremed President and Chief Executive Officer, commented on the financing, "This transaction provides entremed with a non-dilutive financing vehicle that strengt...Aurora-angiogenesis inhibitor in oncology." About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...

EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer

...ic breast cancer (MBC). The data were presented by entremed collaborators during the 2007 Breast Cancer Sympos...ny's web site at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at http://...

EntreMed Presents Mechanism Data for Its Three Lead Oncology Compounds

...rapeutic agents. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, commente...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models

...in inhibitor compounds. The data were presented by entremed scientists at the American Association for Cancer ... identification. Carolyn F. Sidor, M.D., M.B.A., entremed Vice President and Chief Medical Officer, stated, ...quence, leading to cell death (apoptosis). About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...

EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting

...t candidate, ENMD-1198. The data were presented by entremed scientists and collaborators during two separate s...w.entremed.com/">http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at

EntreMed Presents Preclinical Data for MKC-1 in Hematological Cancers

...target="_blank" href= "http://www.entremed.com/">www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's website at http://www.entremed.com . About entremed EntreMed, Inc. is a clinical-stage pharmaceutical company developing ther... other diseases, such as rheumatoid arthritis. Additional information about entremed is available on the Company's web site at entremed Vice President and Chief Medical Officer, commente...s a registered trademark of EntreMed, Inc. About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's web site at

Clinical Results From EntreMed's Panzem NCD and Taxol Breast Cancer Study Presented at ASCO

...anisms of action. Carolyn F. Sidor, M.D., M.B.A, entremed Vice President and Chief Medical Officer, commente...enefit from treatment with Panzem(R) NCD." About entremed EntreMed, Inc. is a clinical-stage pharmaceutica...rheumatoid arthritis. Additional information about entremed is available on the Company's website at
Other Tags
(Date:7/31/2015)... La 10e Conférence internationale sur la ... le BGI du 22 au 25 octobre 2015 ... La conférence célèbre son 10e anniversaire ... est devenue l,une des réunions annuelles mondiales les ... c,est aussi la plus dynamique, la plus enthousiaste ...
(Date:7/30/2015)... July 30, 2015 Cellecta, Inc., a ... function analysis and biomarker discovery, announced the release ... Library targeting all human protein coding genes. CRISPR ... out" a gene,s function. Cellecta,s new Human Whole ... screening tool so that researchers can investigate in ...
(Date:7/21/2015)... 2015 Today, ZTE announced its Android smartphone ... as expected revenues in 2015 that relate to sales of FPC1025 ... of approximately 2,200 MSEK for 2015. Jörgen Lantto, CEO ... manufacturer in China and we are proud ... 5 for Axon , its first ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Coco Libre ... athletes, judges, media, and VIPs at the 2015 Vans US Open of Surfing, July ... water that can claim “no added sugar” on the market, is a natural choice ...
(Date:7/31/2015)... ... , ... According to the article published July 27 on My News LA, a ... extinguished by the city’s fire department before it caused major damage throughout the building. The ... fire, and it was a fire alarm system that tipped off fire fighters so they ...
(Date:7/31/2015)... New York, New York (PRWEB) , ... ... ... Nationally renowned trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence ... from July 28th, 2015 was well received with a 94% approval rating ...
(Date:7/31/2015)... ... July 31, 2015 , ... ... event geared to patients and family members, medical professionals, and researchers, covering a ... experts. The conference is a collaborative effort between the Mesothelioma Applied Research Foundation ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: Don’t Just ... industry’s premier thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at ... attracts over 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers and other ...
Breaking Medicine News(10 mins):Health News:Coco Libre Brings Eco-conscious Hydration to Vans US Open of Surfing 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 2Health News:Article on Recent Pasadena Courtroom Fire Highlights the Effectiveness of Fire Alarm Systems, Says Fire Protection Group Inc 3Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3
Other Contents